Showing all 5 results
Each film coated tablet contains:
Montelukast sodium equivalent to Montelukast …10 mg
Montelukast Sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. Montelukast Sodium is indicated for the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.
Monti should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualized to suit patient needs. Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.Adults and Adolescents 15 Years of Age and Older with Asthma or Allergic Rhinitis: The dosage for adults and adolescents 15 years of age and older is one 10-mg tablet daily.Pediatric Patients 6 to 14 Years of Age with Asthma or Allergic Rhinitis:
The dosage for pediatric patients 6 to 14 years of age is one 5-mg chewable tablet daily.
No dosage adjustment within this age group is necessary.
Each chewable tablet contains:
Montelukast sodium equivalent to Montelukast …5 mg
Montelukast Sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. Montelukast Sodium is indicated for the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.
Monti should be taken once daily. For asthma, the dose should be taken in the evening. For allergic rhinitis, the time of administration may be individualized to suit patient needs. Patients with both asthma and allergic rhinitis should take only one tablet daily in the evening.Adults and Adolescents 15 Years of Age and Older with Asthma or Allergic Rhinitis: The dosage for adults and adolescents 15 years of age and older is one 10-mg tablet daily.
Pediatric Patients 6 to 14 Years of Age with Asthma or Allergic Rhinitis:
The dosage for pediatric patients 6 to 14 years of age is one 5-mg chewable tablet daily.
No dosage adjustment within this age group is necessary.
Each film coated tablet contains:
Rosuvastatin calcium equivalent to Rosuvastatin 10mg
Hyperlipidemia and Mixed Dyslipidemia
Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.
10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further 4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day
Each film coated tablet contains:
Rosuvastatin calcium equivalent to Rosuvastatin 20mg
Hyperlipidemia and Mixed Dyslipidemia
Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.
10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further 4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day
Each film coated tablet contains:
Rosuvastatin calcium equivalent to Rosuvastatin 5mg
Hyperlipidemia and Mixed Dyslipidemia
Rosuvastatin is indicated as adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, non HDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate.
10mg once daily, increased if necessary after ot less than 4 weeks to 20mg once daily,Increased after further 4 weeks to 40mg only in severs hypercholesterolaemia with high cardiovascular risk and under specialist supervision, patient of angina Max.20mg per day